The T-cell—the all-powerful immune system player—is at the core of groundbreaking research at the UCLA Jonsson Comprehensive Cancer Center. Researchers collaborate across disciplines such as oncology, immunology and virology to genetically engineer T-cells and translate their discoveries into treatment strategies for a wide range of cancer types. Working with the PICI network, UCLA investigators are furthering research to learn more about the immune system’s role in the fight against cancer. Antoni Ribas, MD, PhD | Director Owen Witte, MD | Co-Director All Investigators Related Announcement, Our Impact, Research Update New CAR-T Approach Shows Promise for Lymphoma Patients Announcement PICI Young Investigator Retreat 2019 Research Update Colorectal cancer genetics study sheds light on why some patients are resistant to treatment Announcement PICI 2024: Collaborative Breakthroughs in Cancer Immunotherapy Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research Announcement PICI Network Investigators Propel Immunotherapy Progress at SITC 2024 Announcement, Press Release PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy Announcement, Press Release Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer
Research Update Colorectal cancer genetics study sheds light on why some patients are resistant to treatment
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research
Announcement, Press Release PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy
Announcement, Press Release Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn
Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer